Japanese regulators give Athersys permission to start stem cell trial – Crain’s Cleveland Business
|
Japanese regulators give Athersys permission to start stem cell trial
Crain’s Cleveland Business Athersys Inc. has received permission to begin testing its adult stem cell therapy on stroke patients in Japan — a country that could be key to the Cleveland company's future. If MultiStem performs well in the Japanese clinical trial, regulators there … |
